Mild cognitive impairment is a "grey area" between normal age-related memory loss and dementia, and is defined as objectively impaired neuropsychological test performance but intact activities of daily living.
NB: Cognitive Enhancing Medication (e.g Donezepil) is not indicated in mild cognitive impairment, and maybe potentially harmful.
Any patient in whom there is a concern regarding their cognition a Montreal Cognitive Assessment (MoCA) assessment should be performed. A final total MoCA score of 26 and above is considered normal.
Disclaimer: This site is intended to be flexible and frequently updated. While every effort has been made to ensure accuracy, all information should be verified.